Cargando…
Striatal Dopamine D(2/3) Receptor Availability in Treatment Resistant Depression
Several studies demonstrated improvement of depressive symptoms in treatment resistant depression (TRD) after administering dopamine agonists which suggest abnormal dopaminergic neurotransmission in TRD. However, the role of dopaminergic signaling through measurement of striatal dopamine D(2/3) rece...
Autores principales: | de Kwaasteniet, Bart P., Pinto, Chedwa, Ruhé, Eric H. G., van Wingen, Guido A., Booij, Jan, Denys, Damiaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239080/ https://www.ncbi.nlm.nih.gov/pubmed/25411966 http://dx.doi.org/10.1371/journal.pone.0113612 |
Ejemplares similares
-
Correction: Striatal Dopamine D(2/3) Receptor Availability in Treatment Resistant Depression
por: de Kwaasteniet, Bart P., et al.
Publicado: (2015) -
Decreased Resting-State Connectivity between Neurocognitive Networks in Treatment Resistant Depression
por: de Kwaasteniet, Bart P., et al.
Publicado: (2015) -
Lower striatal dopamine D(2/3 )receptor availability in obese compared with non-obese subjects
por: de Weijer, Barbara A, et al.
Publicado: (2011) -
Doubt in the Insula: Risk Processing in Obsessive-Compulsive Disorder
por: Luigjes, Judy, et al.
Publicado: (2016) -
Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients
por: Zaaijer, Eline R., et al.
Publicado: (2015)